Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Severe acute respiratory failure due to a multifactorial diffuse alveolar haemorrhage.

Crisafulli E, Burgazzi B, Majori M, Serra W, Chetta A.

Respirol Case Rep. 2020 Mar 8;8(3):e00531. doi: 10.1002/rcr2.531. eCollection 2020 Apr.

2.
3.

Baseline Exercise Tolerance and Perceived Dyspnea to Identify the Ideal Candidate to Pulmonary Rehabilitation: A Risk Chart in COPD Patients.

Costi S, Crisafulli E, Trianni L, Beghè B, Faverzani S, Scopelliti G, Chetta A, Clini E.

Int J Chron Obstruct Pulmon Dis. 2019 Dec 27;14:3017-3023. doi: 10.2147/COPD.S223038. eCollection 2019.

4.

Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease.

Alfieri V, Crisafulli E, Visca D, Chong WH, Stock C, Mori L, de Lauretis A, Tsipouri V, Chua F, Kouranos V, Kokosi M, Hogben C, Molyneaux PL, George PM, Maher TM, Chetta AA, Sestini P, Wells AU, Renzoni EA.

Eur Respir J. 2020 Feb 20;55(2). pii: 1901681. doi: 10.1183/13993003.01681-2019. Print 2020 Feb. No abstract available.

PMID:
31699833
5.

A pulmonary infection by Actinomyces odontolyticus and Veillonella atypica in an immunocompetent patient with dental caries.

Crisafulli E, Bernardinello N, Alfieri V, Pellegrino F, Lazzari C, Gnetti L, Chetta A.

Respirol Case Rep. 2019 Sep 30;7(9):e00493. doi: 10.1002/rcr2.493. eCollection 2019 Dec.

6.

Delayed Death by Plastid Inhibition in Apicomplexan Parasites.

Kennedy K, Crisafulli EM, Ralph SA.

Trends Parasitol. 2019 Oct;35(10):747-759. doi: 10.1016/j.pt.2019.07.010. Epub 2019 Aug 16. Review.

PMID:
31427248
7.

Minimum Clinically Important Difference in 30-s Sit-to-Stand Test After Pulmonary Rehabilitation in Subjects With COPD.

Zanini A, Crisafulli E, D'Andria M, Gregorini C, Cherubino F, Zampogna E, Azzola A, Spanevello A, Schiavone N, Chetta A.

Respir Care. 2019 Oct;64(10):1261-1269. doi: 10.4187/respcare.06694. Epub 2019 Jul 3.

PMID:
31270178
8.

Hospitalized acute exacerbations of chronic obstructive pulmonary disease: which patients may have a negative clinical outcome?

Crisafulli E, Torres A.

Expert Rev Respir Med. 2019 Aug;13(8):691-693. doi: 10.1080/17476348.2019.1635459. Epub 2019 Jul 3. No abstract available.

PMID:
31241390
9.

Reduced exercise ventilatory efficiency in adults with cystic fibrosis and normal to moderately impaired lung function.

Di Paolo M, Teopompi E, Savi D, Crisafulli E, Longo C, Tzani P, Longo F, Ielpo A, Pisi G, Cimino G, Simmonds NJ, Neder JA, Chetta A, Palange P.

J Appl Physiol (1985). 2019 Aug 1;127(2):501-512. doi: 10.1152/japplphysiol.00030.2019. Epub 2019 Jun 20.

PMID:
31219769
10.

The value of high-resolution computed tomography (HRCT) to determine exercise ventilatory inefficiency and dynamic hyperinflation in adult patients with cystic fibrosis.

Crisafulli E, Teopompi E, Luceri S, Longo F, Tzani P, Pagano P, Ielpo A, Longo C, Di Paolo M, Sverzellati N, Palange P, Chetta A, Pisi G.

Respir Res. 2019 Apr 24;20(1):78. doi: 10.1186/s12931-019-1044-8.

11.

Cough, a vital reflex. mechanisms, determinants and measurements.

Andrani F, Aiello M, Bertorelli G, Crisafulli E, Chetta A.

Acta Biomed. 2019 Jan 15;89(4):477-480. doi: 10.23750/abm.v89i4.6182.

12.

Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study.

Crisafulli E, Ielpo A, Barbeta E, Ceccato A, Huerta A, Gabarrús A, Soler N, Chetta A, Torres A.

Respir Res. 2018 Dec 27;19(1):261. doi: 10.1186/s12931-018-0951-4.

13.

Carfilzomib: A Tale of a Heartbreaking Moment: Case Report and Concise Review of the Literature.

Serra W, Fantin A, Longo C, Rabia G, De Rosa F, Plenteda C, Re F, Crisafulli E, Chetta A.

Cardiovasc Hematol Disord Drug Targets. 2019;19(3):253-258. doi: 10.2174/1871529X19666181205100705.

PMID:
30516116
14.

Pleuritis with pleural effusion due to a Bacillus megaterium infection.

Crisafulli E, Aredano I, Valzano I, Burgazzi B, Andrani F, Chetta A.

Respirol Case Rep. 2018 Nov 28;7(1):e00381. doi: 10.1002/rcr2.381. eCollection 2019 Jan.

15.

A High Degree of Dyspnea Is Associated With Poor Maximum Exercise Capacity in Subjects With COPD With the Same Severity of Air-Flow Obstruction.

Crisafulli E, Aiello M, Tzani P, Ielpo A, Longo C, Alfieri V, Bertorelli G, Chetta A.

Respir Care. 2019 Apr;64(4):390-397. doi: 10.4187/respcare.06336. Epub 2018 Nov 13.

16.

Flow and volume response to bronchodilator in patients with COPD.

Vigna M, Aiello M, Bertorelli G, Crisafulli E, Chetta A.

Acta Biomed. 2018 Oct 8;89(3):332-336. doi: 10.23750/abm.v89i3.5631. Review.

17.

Pulmonary hernia: Case report and review of the literature.

Scelfo C, Longo C, Aiello M, Bertorelli G, Crisafulli E, Chetta A.

Respirol Case Rep. 2018 Oct 2;6(8):e00354. doi: 10.1002/rcr2.354. eCollection 2018 Nov.

18.

Management of severe acute exacerbations of COPD: an updated narrative review.

Crisafulli E, Barbeta E, Ielpo A, Torres A.

Multidiscip Respir Med. 2018 Oct 2;13:36. doi: 10.1186/s40248-018-0149-0. eCollection 2018. Review.

19.

Looking for Predictors of Early Readmission in Chronic Obstructive Pulmonary Disease: Every Effort Is Required.

Crisafulli E, Guerrero M, Ielpo A, Chetta A, Torres A.

Ann Am Thorac Soc. 2018 Nov;15(11):1366. doi: 10.1513/AnnalsATS.201807-458LE. No abstract available.

PMID:
30141969
20.

Heart rate recovery is associated with ventilatory constraints and excess ventilation during exercise in patients with chronic obstructive pulmonary disease.

Crisafulli E, Vigna M, Ielpo A, Tzani P, Mangia A, Teopompi E, Aiello M, Alfieri V, Bertorelli G, Palange P, Chetta A.

Eur J Prev Cardiol. 2018 Oct;25(15):1667-1674. doi: 10.1177/2047487318789756. Epub 2018 Jul 23.

PMID:
30033754
21.

Spot the trachea! A wide paratracheal air cyst of not easy definition.

Crisafulli E, Lazzari C, Longo C, Bernardinello N, Alfieri V, Chetta A.

Acta Biomed. 2018 Jun 7;89(2):260-261. doi: 10.23750/abm.v89i2.5610.

22.

Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis.

Crisafulli E, Guerrero M, Ielpo A, Ceccato A, Huerta A, Gabarrús A, Soler N, Chetta A, Torres A.

Sci Rep. 2018 Jun 18;8(1):9236. doi: 10.1038/s41598-018-27680-y.

23.

Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease.

Estirado C, Ceccato A, Guerrero M, Huerta A, Cilloniz C, Vilaró O, Gabarrús A, Gea J, Crisafulli E, Soler N, Torres A.

Respir Res. 2018 Jun 15;19(1):119. doi: 10.1186/s12931-018-0820-1.

24.

When Two Drugs Are Better than Three: Re-Modulating the Therapeutic Plan of a Chronic Obstructive Pulmonary Disease Patient.

Ielpo A, Crisafulli E.

Respiration. 2018;95 Suppl 1:6-10. doi: 10.1159/000487173. Epub 2018 Apr 27.

25.

COPD 2017: A Year in Review.

Crisafulli E, Torres A.

COPD. 2018 Apr;15(2):118-122. doi: 10.1080/15412555.2018.1444022. Epub 2018 Mar 27. Review.

PMID:
29583021
26.

The role of the microbiome in childhood asthma.

Pisi G, Fainardi V, Aiello M, Bertorelli G, Crisafulli E, Chetta A.

Immunotherapy. 2017 Nov;9(15):1295-1304. doi: 10.2217/imt-2017-0048. Review.

PMID:
29130800
27.

Acute exacerbations of COPD: risk factors for failure and relapse.

Mantero M, Rogliani P, Di Pasquale M, Polverino E, Crisafulli E, Guerrero M, Gramegna A, Cazzola M, Blasi F.

Int J Chron Obstruct Pulmon Dis. 2017 Sep 8;12:2687-2693. doi: 10.2147/COPD.S145253. eCollection 2017. Review.

28.

Next generation beta adrenoreceptor agonists for the treatment of asthma.

Crisafulli E, Frizzelli A, Fantin A, Manco A, Mangia A, Pisi G, Fainardi V, Alfieri V, Aiello M, Bertorelli G, Chetta A.

Expert Opin Pharmacother. 2017 Oct;18(14):1499-1505. doi: 10.1080/14656566.2017.1378348. Epub 2017 Sep 14. Review.

PMID:
28891349
29.

Sarcoidosis in an Italian province. Prevalence and environmental risk factors.

Beghè D, Dall'Asta L, Garavelli C, Pastorelli AA, Muscarella M, Saccani G, Aiello M, Crisafulli E, Corradi M, Stacchini P, Chetta A, Bertorelli G.

PLoS One. 2017 May 5;12(5):e0176859. doi: 10.1371/journal.pone.0176859. eCollection 2017.

30.

Asymptomatic peripheral artery disease can limit maximal exercise capacity in chronic obstructive pulmonary disease patients regardless of airflow obstruction and lung hyperinflation.

Crisafulli E, Scelfo C, Tzani P, Aiello M, Bertorelli G, Chetta A.

Eur J Prev Cardiol. 2017 Jun;24(9):990-999. doi: 10.1177/2047487317695629. Epub 2017 Jan 1.

PMID:
28436723
31.

Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of Disease.

Crisafulli E, Pisi R, Aiello M, Vigna M, Tzani P, Torres A, Bertorelli G, Chetta A.

Respiration. 2017;93(1):32-41. Epub 2016 Nov 17.

32.

Transthoracic Echocardiography and Chest Computed Tomography Arteriography in Patients with Acute Pulmonary Embolism: A Two-Year Follow-Up Study.

Serra W, Crisafulli E, Sverzellati N, Ugolotti PT, Tzani P, Marangio E, Ardissino D, Gherli T, Chetta A.

Respiration. 2016;92(4):235-240. Epub 2016 Sep 8.

33.

Relationships between emphysema and airways metrics at High-Resolution Computed Tomography (HRCT) and ventilatory response to exercise in mild to moderate COPD patients.

Crisafulli E, Alfieri V, Silva M, Aiello M, Tzani P, Milanese G, Bertorelli G, Sverzellati N, Chetta A.

Respir Med. 2016 Aug;117:207-14. doi: 10.1016/j.rmed.2016.06.016. Epub 2016 Jun 21.

34.

Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?

Crisafulli E, Guerrero M, Chetta A, Torres A.

Eur Respir J. 2016 Jul;48(1):279-81. doi: 10.1183/13993003.00426-2016. No abstract available.

35.

Are interstitial lung abnormalities associated with COPD? A nested case-control study.

Bozzetti F, Paladini I, Rabaiotti E, Franceschini A, Alfieri V, Chetta A, Crisafulli E, Silva M, Pastorino U, Sverzellati N.

Int J Chron Obstruct Pulmon Dis. 2016 May 26;11:1087-96. doi: 10.2147/COPD.S103256. eCollection 2016.

36.

Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.

Bertino G, Privitera G, Purrello F, Demma S, Crisafulli E, Spadaro L, Koukias N, Tsochatzis EA.

Intern Emerg Med. 2016 Oct;11(7):905-16. doi: 10.1007/s11739-016-1478-7. Epub 2016 Jun 7. Review.

PMID:
27273018
37.

Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study.

Guerrero M, Crisafulli E, Liapikou A, Huerta A, Gabarrús A, Chetta A, Soler N, Torres A.

PLoS One. 2016 Mar 4;11(3):e0150737. doi: 10.1371/journal.pone.0150737. eCollection 2016.

38.

Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.

Crisafulli E, Zanini A, Pisi G, Pignatti P, Poli G, Scuri M, Chetta A.

Expert Rev Respir Med. 2016;10(5):481-90. doi: 10.1586/17476348.2016.1161508. Epub 2016 Mar 16. Review.

PMID:
26938578
39.

Predicting In-Hospital Treatment Failure (≤ 7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids.

Crisafulli E, Torres A, Huerta A, Guerrero M, Gabarrús A, Gimeno A, Martinez R, Soler N, Fernández L, Wedzicha JA, Menéndez R.

COPD. 2016;13(1):82-92. doi: 10.3109/15412555.2015.1057276. Epub 2015 Oct 9.

PMID:
26451913
40.

Endotracheal tubes for critically ill patients: an in vivo analysis of associated tracheal injury, mucociliary clearance, and sealing efficacy.

Li Bassi G, Luque N, Martí JD, Aguilera Xiol E, Di Pasquale M, Giunta V, Comaru T, Rigol M, Terraneo S, De Rosa F, Rinaudo M, Crisafulli E, Peralta Lepe RC, Agusti C, Lucena C, Ferrer M, Fernández L, Torres A.

Chest. 2015 May;147(5):1327-1335. doi: 10.1378/chest.14-1438.

PMID:
25500677
41.

C-Reactive Protein at Discharge, Diabetes Mellitus and ≥ 1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Crisafulli E, Torres A, Huerta A, Méndez R, Guerrero M, Martinez R, Liapikou A, Soler N, Sethi S, Menéndez R.

COPD. 2015 Jun;12(3):306-14. doi: 10.3109/15412555.2014.933954. Epub 2014 Oct 3.

PMID:
25279441
42.

Inhaled corticosteroids do not influence the early inflammatory response and clinical presentation of hospitalized subjects with COPD exacerbation.

Crisafulli E, Guerrero M, Menéndez R, Huerta A, Martinez R, Gimeno A, Soler N, Torres A.

Respir Care. 2014 Oct;59(10):1550-9. doi: 10.4187/respcare.03036. Epub 2014 Jul 29.

43.

Predicting poor prognosis in COPD patients: looking for a lamp lit in the darkness of the night.

Crisafulli E.

Eur Respir J. 2014 Jun;43(6):1560-2. doi: 10.1183/09031936.00045614. No abstract available.

44.

Rehabilitation and supportive therapy in elderly patients with Chronic Obstructive Pulmonary Disease.

Crisafulli E, Morandi A, Olivini A, Malerba M, Clini EM.

Eur J Intern Med. 2014 Apr;25(4):329-35. doi: 10.1016/j.ejim.2014.01.003. Epub 2014 Jan 25. Review.

PMID:
24472694
45.

Biologic therapy for atopic asthma and beyond.

Caruso M, Crisafulli E, Lizzio R, Polosa R.

Curr Opin Allergy Clin Immunol. 2013 Dec;13(6):677-85. doi: 10.1097/ACI.0000000000000012. Review.

PMID:
24152740
46.

Assessment of severity of ICU-acquired pneumonia and association with etiology.

Di Pasquale M, Ferrer M, Esperatti M, Crisafulli E, Giunta V, Li Bassi G, Rinaudo M, Blasi F, Niederman M, Torres A.

Crit Care Med. 2014 Feb;42(2):303-12. doi: 10.1097/CCM.0b013e3182a272a2.

PMID:
23989176
47.

Respiratory muscle training in patients recovering recent open cardiothoracic surgery: a randomized-controlled trial.

Crisafulli E, Venturelli E, Siscaro G, Florini F, Papetti A, Lugli D, Cerulli M, Clini E.

Biomed Res Int. 2013;2013:354276. doi: 10.1155/2013/354276. Epub 2013 Jul 30.

48.

Impact of chronic liver disease in intensive care unit acquired pneumonia: a prospective study.

Di Pasquale M, Esperatti M, Crisafulli E, Ferrer M, Bassi GL, Rinaudo M, Escorsell A, Fernandez J, Mas A, Blasi F, Torres A.

Intensive Care Med. 2013 Oct;39(10):1776-84. doi: 10.1007/s00134-013-3025-6. Epub 2013 Aug 2.

PMID:
23907496
49.

Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics.

Huerta A, Crisafulli E, Menéndez R, Martínez R, Soler N, Guerrero M, Montull B, Torres A.

Chest. 2013 Oct;144(4):1134-1142. doi: 10.1378/chest.13-0488.

PMID:
23828375
50.

Adenosine signaling pathways as potential therapeutic targets in respiratory disease.

Caruso M, Alamo A, Crisafulli E, Raciti C, Fisichella A, Polosa R.

Expert Opin Ther Targets. 2013 Jul;17(7):761-72. doi: 10.1517/14728222.2013.795220. Epub 2013 May 4. Review.

PMID:
23642090

Supplemental Content

Loading ...
Support Center